Hetero is one of worlds leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector. We endeavour to serve patients by moulding science and technology into therapies to improve health outcomes and people’s lives.

Walk in Interview at Bangalore

AstraZeneca Plc has held discussions with U.S.-based Bristol Myers Squibb (BMS) over a potential merger that could create one of the world's largest pharmaceutical companies with a combined market value of nearly $400 billion, according to an exclusive report by the Financial Times, which cited people familiar with the matter.